Restricted accessResearch articleFirst published online 2012-01
Positive Effect on Bone Fusion by the Combination of Platelet-Rich Plasma and a Gelatin β-Tricalcium Phosphate Sponge: A Study Using a Posterolateral Fusion Model of Lumbar Vertebrae in Rats
We developed a novel method for bone fusion by combining platelet-rich plasma (PRP) and a gelatin β-tricalcium phosphate (β-TCP) sponge. The PRP is an autologous concentration of platelets that includes several growth factors. The gelatin β-TCP sponge comprises gelatin and β-TCP, thus enabling the sustained release of growth factors and osteoconduction. To evaluate this method, we generated a posterolateral fusion model of lumbar vertebrae in rats and divided it into five groups by implanting the following materials between transverse processes of vertebrae, (1) the gelatin β-TCP sponge with PRP (PRP sponge), (2) the gelatin β-TCP sponge with platelet-poor plasma, (3) gelatin hydrogel with PRP, (4) autologous iliac bone (autograft), and (5) no material was implanted as a control. The assessment of bone fusion by a radiographic assessment, a biomechanical test, microcomputed tomography, and histological evaluations demonstrated that there were no significant differences between the PRP sponge and the autograft groups regarding the osteogenic effect. Subsequent examinations revealed that no significant differences existed between the PRP sponge and the autograft groups in either biomechanical stiffness or the bone volume over time; whereas the radiographic and histological composition underwent similar changes in the fusion process. These results indicate that the PRP sponge could, therefore, be potentially useful as an attractive and less invasive method for bone fusion.
Get full access to this article
View all access options for this article.
References
1.
SilberJ.S., AndersonD.G., DaffnerS.D., BrislinB.T., LelandJ.M., HilibrandA.S.et al.Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine (Phila Pa 1976), 28:134. 2003.
2.
BodenS.D.Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation. Tissue Eng, 6:383. 2000.
3.
MoghaddamA., ElleserC., BiglariB., WentzensenA., ZimmermannG.Clinical application of BMP 7 in long bone non-unions. Arch Orthop Trauma Surg, 130:71. 2010.
4.
BurkusJ.K., GornetM.F., DickmanC.A., ZdeblickT.A.Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech, 15:337. 2002.
5.
CarreonL.Y., GlassmanS.D., BrockD.C., DimarJ.R., PunoR.M., CampbellM.J.Adverse events in patients re-exposed to bone morphogenetic protein for spine surgery. Spine (Phila Pa 1976), 33:391. 2008.
6.
SmuckerJ.D., RheeJ.M., SinghK., YoonS.T., HellerJ.G.Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976), 31:2813. 2006.
7.
MindeaS.A., ShihP., SongJ.K.Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review. Spine (Phila Pa 1976), 34:1480discussion 52009.
8.
TrounsonA.New perspectives in human stem cell therapeutic research. BMC Med, 7:29. 2009.
9.
KraiwattanapongC., BodenS.D., Louis-UgboJ., AttallahE., BarnesB., HuttonW.C.Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion. Spine (Phila Pa 1976), 30:1001discussion 72005.
10.
NeenD., NoyesD., ShawM., GwilymS., FairlieN., BirchN.Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft. Spine (Phila Pa 1976), 31:E636. 2006.
11.
TabataY.Biomaterial technology for tissue engineering applications. J R Soc Interface, 6,Suppl 3:S311. 2009.
12.
GottfriedO.N., DaileyA.T.Mesenchymal stem cell and gene therapies for spinal fusion. Neurosurgery, 63:380. 2008.
13.
WeibrichG., KleisW.K., HafnerG., HitzlerW.E.Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg, 30:97. 2002.
14.
EppleyB.L., WoodellJ.E., HigginsJ.Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg, 114:1502. 2004.
15.
CervellinM., de GirolamoL., BaitC., DentiM., VolpiP.Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: a randomized, controlled clinical study. Knee Surg Sports Traumatol Arthrosc, 2011[Epub ahead of print]10.1007/s00167-011-1570-5.
16.
OgundipeO.K., UgbokoV.I., OwotadeF.J.Can autologous platelet-rich plasma gel enhance healing after surgical extraction of mandibular third molars?J Oral Maxillofac Surg, 2011[Epub ahead of print]10.1016/j.joms.2011.02.014.
17.
SarkarM.R., AugatP., ShefelbineS.J., SchorlemmerS., Huber-LangM., ClaesL.et al.Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold. Biomaterials, 27:1817. 2006.
18.
BassiA.P., CarvalhoP.S.Repair of bone cavities in dog's mandible filled with inorganic bovine bone and bioactive glass associated with platelet rich plasma. Braz Dent J, 22:14. 2011.
19.
TakahashiY., YamamotoM., TabataY.Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and beta-tricalcium phosphate. Biomaterials, 26:3587. 2005.
20.
TabataY.Potential of drug delivery technology in tissue regeneration therapy. J Hard Tissue Biol, 15:73. 2006.
21.
KastenP., BeyenI., BormannD., LuginbuhlR., PlogerF., RichterW.The effect of two point mutations in GDF-5 on ectopic bone formation in a beta-tricalciumphosphate scaffold. Biomaterials, 31:3878. 2010.
LuS.S., ZhangX., SooC., HsuT., NapoliA., AghalooT.et al.The osteoinductive properties of Nell-1 in a rat spinal fusion model. Spine J, 7:50. 2007.
24.
NamikawaT., TeraiH., HoshinoM., KatoM., ToyodaH., YanoK.et al.Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model. Spine (Phila Pa 1976), 32:2294. 2007.
25.
IntiniG.The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials, 30:4956. 2009.
26.
ZhangH., AhmadM., GronowiczG.Effects of transforming growth factor-beta 1 (TGF-beta1) on in vitro mineralization of human osteoblasts on implant materials. Biomaterials, 24:2013. 2003.
27.
MehtaV.Platelet-rich plasma: a review of the science and possible clinical applications. Orthopedics, 33:111. 2010.
28.
Lopez-VidrieroE., GouldingK.A., SimonD.A., SanchezM., JohnsonD.H.The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy, 26:269. 2010.
29.
Martinez-ZapataM.J., Marti-CarvajalA., SolaI., BolibarI., Angel ExpositoJ., RodriguezL.et al.Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. Transfusion, 49:44. 2009.
30.
LatalskiM., ElbatrawyY.A., ThabetA.M., GregosiewiczA., RaganowiczT., FatygaM.Enhancing bone healing during distraction osteogenesis with platelet-rich plasma. Injury, 42:821. 2011.
31.
CarvalhoM.D., SuaidF.F., SantamariaM.P., CasatiM.Z., NocitiF.H.Jr., SallumA.W., SallumE.A.Platelet-rich plasma plus bioactive glass in the treatment of intra-bony defects: a study in dogs. J Appl Oral Sci, 19:82. 2011.
32.
PuolakkainenP.A., TwardzikD.R., RanchalisJ.E., PankeyS.C., ReedM.J., GombotzW.R.The enhancement in wound healing by transforming growth factor-beta 1 (TGF-beta 1) depends on the topical delivery system. J Surg Res, 58:321. 1995.
33.
MatsumotoG., OmiY., KubotaE., OzonoS., TsuzukiH., KinoshitaY.et al.Enhanced regeneration of critical bone defects using a biodegradable gelatin sponge and beta-tricalcium phosphate with bone morphogenetic protein-2. J Biomater Appl, 24:327. 2009.
34.
BoddeE.W., WolkeJ.G., KowalskiR.S., JansenJ.A.Bone regeneration of porous beta-tricalcium phosphate (Conduit TCP) and of biphasic calcium phosphate ceramic (Biosel) in trabecular defects in sheep. J Biomed Mater Res A, 82:711. 2007.
35.
KondoN., OgoseA., TokunagaK., UmezuH., AraiK., KudoN.et al.Osteoinduction with highly purified beta-tricalcium phosphate in dog dorsal muscles and the proliferation of osteoclasts before heterotopic bone formation. Biomaterials, 27:4419. 2006.
36.
YuanH., van BlitterswijkC.A., de GrootK., de BruijnJ.D.Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds. Tissue Eng, 12:1607. 2006.
37.
KoharaH., TabataY.Enhancement of ectopic osteoid formation following the dual release of bone morphogenetic protein 2 and Wnt1 inducible signaling pathway protein 1 from gelatin sponges. Biomaterials, 32:5726. 2011.
38.
RatanavarapornJ., FuruyaH., KoharaH., TabataY.Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials, 32:2797. 2011.
39.
LiH., ZouX., XueQ., EgundN., LindM., BüngerC.Anterior lumbar interbody fusion with carbon fiber cage loaded with bioceramics and platelet-rich plasma. An experimental study on pigs. Eur Spine J, 13:354. 2004.
40.
ScholzM., SchleicherP., EindorfT., FriedersdorffF., GelinskyM., KönigU., SewingA., HaasN.P., KandzioraF.Cages augmented with mineralized collagen and platelet-rich plasma as an osteoconductive/inductive combination for interbody fusion. Spine (Phila Pa 1976), 35:740. 2010.
41.
FanC.L., GaoP.J., GuY.J., TangX.F., LiuJ.J., WeiJ.et al.Therapeutic angiogenesis by intramuscular injection of fibrin particles into ischaemic hindlimbs. Clin Exp Pharmacol Physiol, 33:617. 2006.
42.
MosessonM.W.Fibrinogen and fibrin structure and functions. J Thromb Haemost, 3:1894. 2005.
43.
FindikciogluK., FindikciogluF., YavuzerR., ElmasC., AtabayK.Effect of platelet-rich plasma and fibrin glue on healing of critical-size calvarial bone defects. J Craniofac Surg, 20:34. 2009.
44.
TorigoeI., SotomeS., TsuchiyaA., YoshiiT, MaeharaH, SugataYet al.Bone regeneration with autologous plasma, bone marrow stromal cells, and porous beta-tricalcium phosphate in nonhuman primates. Tissue Eng Part A, 15:1489. 2009.
45.
JoyceM.E., RobertsA.B., SpornM.B., BolanderM.E.Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol, 110:2195. 1990.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
